2008
DOI: 10.1038/bjp.2008.115
|View full text |Cite
|
Sign up to set email alerts
|

Bone morphogenetic protein signalling is required for the anti‐mitogenic effect of the proteasome inhibitor MG‐132 on colon cancer cells

Abstract: Background and purpose: Inhibition of proteasome has been emerging as a promising approach in pathway-directed cancer therapy. Bone morphogenetic protein (BMP) signalling, which is known to be regulated by the ubiquitin-proteasome pathway in osteoblasts, plays a crucial role in the suppression of gastrointestinal carcinogenesis. Here we sought to elucidate the antimitogenic effect of a proteasome inhibitor in relation to BMP signalling in colon cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
12
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(16 citation statements)
references
References 34 publications
4
12
0
Order By: Relevance
“…For example, MG132 affected the proliferation of lens epithelial cells (LECs) during the development of posterior capsular opacification (Awasthi and Wagner, 2006). In ovarian cancer cells, MG132 suppressed cell division in part by increasing the levels of p21 and p27 proteins (Bazzaro et al, 2006), while in gastric and colon cancer cells this inhibitor suppressed cell division via activation of BMP signaling (Wu et al, 2008). …”
Section: Discussionmentioning
confidence: 99%
“…For example, MG132 affected the proliferation of lens epithelial cells (LECs) during the development of posterior capsular opacification (Awasthi and Wagner, 2006). In ovarian cancer cells, MG132 suppressed cell division in part by increasing the levels of p21 and p27 proteins (Bazzaro et al, 2006), while in gastric and colon cancer cells this inhibitor suppressed cell division via activation of BMP signaling (Wu et al, 2008). …”
Section: Discussionmentioning
confidence: 99%
“…Firstly, MG132 could inhibit the proteasome pathway mediated degradation of Smad proteins, and so contribute to the elevated Smad protein levels and enhance the activation of Smad proteins. Secondly, it has been shown that the expression of BMP-2 could be up-regulated by MG132 [49,50]. Thus, MG132, together with mechanical strain, might up-regulate BMP-2 expression, and this can lead to the increase in Smad activation and ALP expression.…”
Section: Discussionmentioning
confidence: 99%
“…Although BMPs are expressed in many tumors [25], no cases of malignancy have been reported as a direct result of BMP application. The effect of local application of BMPs in cases of existing malignancies remains controversial; a beneficial effect of BMP-7 or BMP signaling in inhibiting cancer cells has been reported [5,6,17,33], while other studies [18,19] have reported a negative effect. Several authors have indicated that OP-1 does not seem to have a carcinogenic effect [25,28,30].…”
Section: Discussionmentioning
confidence: 99%